Clinical Trials Browser

Hodgkin Disease

Sarcoma, Ewing

Breast Neoplasms

Triple Negative Breast Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Leiomyosarcoma, Sarcoma

Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms

Hodgkin Disease, Recurrence

Burkitt Lymphoma, Lymphoma, B-Cell

Invasive Breast Cancer

Breast Neoplasms

Lymphoma, Large B-Cell, Diffuse

Uterine Cervical Neoplasms, Ovarian Neoplasms, Vaginal Neoplasms, Vulvar Neoplasms, Endometrial Neoplasms, Adenocarcinoma, Clear Cell

Ovarian Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Rhabdomyosarcoma, Sarcoma, Sarcoma, Ewing, Osteosarcoma

Ovarian Cancer Recurrent

HER-2 Positive Breast Cancer

Breast Neoplasms

Breast Neoplasms

Ovarian Neoplasms

Fallopian Tube Neoplasms, Ovarian Neoplasms

Advanced Solid Tumors

HER2-negative Breast Cancer

Liposarcoma, Sarcoma

Her2-negative Metastatic Breast Cancer

Ovarian Neoplasms

Breast Neoplasms, Neoplasms, Triple Negative Breast Neoplasms

Breast Neoplasms, Neoplasms

Ovarian Neoplasms

Triple Negative Breast Neoplasms

Breast Neoplasms

Hodgkin Disease

Multiple Myeloma

Hodgkin Disease

Breast Neoplasms

Breast Neoplasms

Lymphoma, Lymphoma, Follicular, Lymphoma, Non-Hodgkin, Lymphoma, Large-Cell, Immunoblastic, Lymphoma, Large B-Cell, Diffuse, Lymphoma, Mantle-Cell

Ovarian Neoplasms

Ovarian Neoplasms

Breast Neoplasms

Breast Neoplasms, Triple Negative Breast Neoplasms

Ovarian Neoplasms

Ovarian Neoplasms

Clinical Trials

ctDNA-Guided Therapy for Relapsed/Refractory Hodgkin Lymphoma

METTSEO

CARABELA

A Cancer Vaccine (STEMVAC) in Combination With Chemotherapy for the Treatment of PD-L1 Negative Metastatic Triple-Negative Breast Cancer

Surgery and Chemotherapy With or Without Chemotherapy After Surgery in Treating Patients With Ovarian, Fallopian Tube, Uterine, or Peritoneal Cancer

Tamoxifen and Pegylated Liposomal Doxorubicin for the Treatment of Patients With Metastatic or Inoperable, Locally Advanced Triple Negative Breast Cancer

Combination Chemotherapy and Bevacizumab With the NovoTTF-100L(P) System in Treating Participants With Advanced, Recurrent, or Refractory Hepatic Metastatic Cancer

Neoadjuvant Carbo/Paclitaxel Followed by Doxorubicin/Cyclophosphamide in Breast Cancer

Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

Doxorubicin Plus Dual Checkpoint Blockade for Soft Tissue Sarcomas

A Precision Medicine Approach (SMMART-ACT) for the Treatment of Patients With Advanced Sarcoma, Prostate, Breast, Ovarian or Pancreatic Cancer

Phase II Study of Second- Line Pembrolizumab Plus GVD for Relapsed or Refractory Hodgkin Lymphoma

LONCA

CemiHALT

CD40 Agonist, Flt3 Ligand, and Chemotherapy in HER2 Negative Breast Cancer

BV mini CHP

DOVE

SCENIC

InCITe

Carboplatin and Combination Chemotherapy With or Without Veliparib in Treating Patients With Stage IIB-IIIC Breast Cancer

Disulfiram With Copper Gluconate and Liposomal Doxorubicin in Treatment-Refractory Sarcomas

Pegylated Liposomal Doxorubicin Plus Adebrelimab With or Without Mirabegron in Relapsed Ovarian Cancer

met-HEReMYTA

Study of Tucatinib and Doxil in Participants With Human Epidermal Growth Factor Receptor 2 Positive (HER2+) Metastatic Breast Cancer

SAFIR02_Breast

Caelyx Biweekly in Heavily Pretreated Patients With Relapsed Ovarian Cancer

Avatar-Directed Chemotherapy in Treating Patients With Ovarian, Primary Peritoneal, or Fallopian Tube Cancer

Study to Assess TOPO2A as a Biomarker for Sensitivity to Doxorubicin/Doxil in Soft Tissue Sarcoma

TLD-1, a Novel Liposomal Doxorubicin, in Patients With Advanced Solid Tumors

ORIENTA

First-line Treatment of Advanced/unresectable DDLPS

EASOVCWDITHABC

PEMBOV

ALICE

ICON

ANITA

Liposomal Doxorubicin, Bevacizumab, and Everolimus in Patients With Locally Advanced TNBC With Tumors Predicted Insensitive to Standard Chemotherapy; A Moonshot Initiative

Neoadjuvant Treatment Pegylated Liposomal Doxorubicin Plus Cyclophosphamide Sequential Docetaxel Plus Trastuzumab and Pertuzumab Versus Docetaxel Plus Carboplatin Combined With Trastuzumab and Pertuzumab in HER-2 Positive Breast Cancer

BV-AVD-R Treatment Children Hodgkin's Lymphoma

ATG-010(Selinexor) in Combination With Chemotherapy in RRMM

Brentuximab for Newly Diagnosed Hodgkin Disease

CAELYX® as Adjuvant Treatment in Early Stage Luminal B Breast Cancer BREAST CANCER

Biomarkers in Women Receiving Chemotherapy & Celecoxib for Stage II or Stage III Breast Cancer Removable by Surgery

Vaccine Therapy Plus Sargramostim Following Chemotherapy in Previously Untreated Aggressive Non-Hodgkin's Lymphoma

MYCA

Circulating Tumor DNA Monitoring in Platinum-resistant Ovarian Cancer

Caelyx, Cyclophosphamide and Herceptin in Patients With Metastatic Breast Cancer

Pegylated Liposomal Doxorubicin Hydrochloride and Carboplatin Followed by Surgery and Paclitaxel in Treating Patients With Triple Negative Stage II-III Breast Cancer

MITO-2: A Study Comparing 2 Chemotherapy Regimens (Carboplatin/Liposomal Doxorubicin vs Carboplatin/Paclitaxel) in Patients With Ovarian Cancer

MITO16MANGO2b